SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-002484
Filing Date
2023-11-14
Accepted
2023-11-14 16:32:24
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nnvc-20230930x10q.htm   iXBRL 10-Q 1018776
2 EX-31.1 nnvc-20230930xex31d1.htm EX-31.1 14171
3 EX-31.2 nnvc-20230930xex31d2.htm EX-31.2 14183
4 EX-32.1 nnvc-20230930xex32d1.htm EX-32.1 8223
5 EX-32.2 nnvc-20230930xex32d2.htm EX-32.2 7866
  Complete submission text file 0001410578-23-002484.txt   4658471

Data Files

Seq Description Document Type Size
6 EX-101.SCH nnvc-20230930.xsd EX-101.SCH 39836
7 EX-101.CAL nnvc-20230930_cal.xml EX-101.CAL 30046
8 EX-101.DEF nnvc-20230930_def.xml EX-101.DEF 176979
9 EX-101.LAB nnvc-20230930_lab.xml EX-101.LAB 313661
10 EX-101.PRE nnvc-20230930_pre.xml EX-101.PRE 254853
54 EXTRACTED XBRL INSTANCE DOCUMENT nnvc-20230930x10q_htm.xml XML 673574
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 937-6137
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

IRS No.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36081 | Film No.: 231407087
SIC: 2834 Pharmaceutical Preparations